Identifying and understanding determinants of high healthcare costs for breast cancer: a quantile regression machine learning approach.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 2,938 episodes from 2012–2018, chemotherapy drug and interval were prominent high-cost correlates; quantile analysis attributed 77% of reduced out-of-bag quantile loss to chemotherapy variables. Retrospective associations do not establish that changing a treatment or cost driver will causally reduce healthcare expenditures.
Technology: Quantile regression forests ranked variables associated with high-tail breast-cancer care expenditures in Oncology Care Model episodes.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Quantile regression forests ranked variables associated with high-tail breast-cancer care expenditures in Oncology Care Model episodes.
- Test and result
- In 2,938 episodes from 2012–2018, chemotherapy drug and interval were prominent high-cost correlates; quantile analysis attributed 77% of reduced out-of-bag quantile loss to chemotherapy variables.
- Limitation / still unknown
- Retrospective associations do not establish that changing a treatment or cost driver will causally reduce healthcare expenditures.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12913-020-05936-6
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.